ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
15.09
-0.30 (-1.95%)
At close: Jun 16, 2025, 12:35 PM

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending March 31, 2025, ARS Pharmaceuticals generated $7.97M in revenue.
Revenue (ttm)
$89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
$575.15K
Employees
155
Market Cap
1.48B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.